[144] Astera Labs, Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

144

08/07/2025 - 04:25 PM

144: Filer Information

Filer CIK

Filer CCC

Is this a LIVE or TEST Filing?

LIVE TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common

Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York NY 10004

280000

48829200.00

166219140

08/07/2025

NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common

11/21/2017

Private Acquisition from Issuer or an Affiliate

Issuer

280000

11/21/2017

N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

10b5-1 Sales for SN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

07/09/2025

20000

1964360.00

10b5-1 Sales for NAVAD TRUST U/A DTD 11/01/2012
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

07/09/2025

125000

12341525.00

10b5-1 Sales for RN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

07/09/2025

20000

1964156.00

10b5-1 Sales for SN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

06/18/2025

9257

909007.78

10b5-1 Sales for NAVAD TRUST U/A DTD 11/01/2012
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

06/18/2025

57859

5696131.76

10b5-1 Sales for RN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

06/18/2025

9257

908969.82

10b5-1 Sales for SN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

06/04/2025

10743

1053989.28

10b5-1 Sales for NAVAD TRUST U/A DTD 11/01/2012
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

06/04/2025

67141

6587163.23

10b5-1 Sales for RN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

06/04/2025

10743

1053989.28

10b5-1 Sales for SN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

05/27/2025

20000

1963454.00

10b5-1 Sales for NAVAD TRUST U/A DTD 11/01/2012
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

05/27/2025

125000

12283975.00

10b5-1 Sales for RN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

05/27/2025

20000

1963500.00

SANJAY GAJENDRA
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

05/16/2025

91337

8281408.26

10b5-1 Sales for SN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

05/08/2025

20000

1435544.00

10b5-1 Sales for NAVAD TRUST U/A DTD 11/01/2012
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

05/08/2025

125000

8970162.50

10b5-1 Sales for RN2021 IRREVOCABLE TRUST U/A DTD06/10/2021
2901 Tasman Drive Suite 205
Santa Clara CA 95054

Common

05/08/2025

20000

1435368.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Source:

AG真人官方